Jeffrey How

11PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 01, 2026
Efficacy of everolimus and letrozole with or without ribociclib in recurrent endometrial cancer: a phase 2 randomized clinical trial.

|Jun 25, 2026
Pregnancy Outcomes After in Utero Exposure to Immune Checkpoint Inhibitors.

|Aug 01, 2025
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities.

Anne Knisely, Yibo Dai, Graham L Barlow

|Nov 11, 2024
A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma.

Mohamed A Gouda, Bettzy Stephen, Yanyan Tian

|Oct 12, 2024
TERT promoter mutations and survival outcomes in adult-type granulosa cell tumors.

Allison L Brodsky, Alejandra Flores Legarreta, Bryan M Fellman

|Aug 28, 2024
Translating biological insights into improved management of endometrial cancer.

Jeffrey A How, Amir A Jazaeri, Shannon N Westin

Pageof 2

Frequent Collaborators

3 joint publications

Amir A Jazaeri

3 joint publications

Shannon N Westin

3 joint publications

Anil K Sood

2 joint publications

Aung Naing